Glaukos Revenue 2014-2023 | GKOS

Glaukos annual/quarterly revenue history and growth rate from 2014 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Glaukos revenue for the quarter ending December 31, 2023 was $0.082B, a 15.64% increase year-over-year.
  • Glaukos revenue for the twelve months ending December 31, 2023 was $0.315B, a 11.26% increase year-over-year.
  • Glaukos annual revenue for 2023 was $0.315B, a 11.26% increase from 2022.
  • Glaukos annual revenue for 2022 was $0.283B, a 3.79% decline from 2021.
  • Glaukos annual revenue for 2021 was $0.294B, a 30.7% increase from 2020.
Glaukos Annual Revenue
(Millions of US $)
2023 $315
2022 $283
2021 $294
2020 $225
2019 $237
2018 $181
2017 $159
2016 $114
2015 $72
2014 $46
2013 $21
Glaukos Quarterly Revenue
(Millions of US $)
2023-12-31 $82
2023-09-30 $78
2023-06-30 $80
2023-03-31 $74
2022-12-31 $71
2022-09-30 $71
2022-06-30 $73
2022-03-31 $68
2021-12-31 $73
2021-09-30 $75
2021-06-30 $78
2021-03-31 $68
2020-12-31 $73
2020-09-30 $65
2020-06-30 $32
2020-03-31 $55
2019-12-31 $66
2019-09-30 $59
2019-06-30 $59
2019-03-31 $54
2018-12-31 $54
2018-09-30 $44
2018-06-30 $43
2018-03-31 $40
2017-12-31 $42
2017-09-30 $40
2017-06-30 $41
2017-03-31 $36
2016-12-31 $33
2016-09-30 $30
2016-06-30 $29
2016-03-31 $23
2015-12-31 $20
2015-09-30 $19
2015-06-30 $18
2015-03-31 $15
2014-12-31 $14
2014-09-30 $12
2014-06-30 $11
2014-03-31 $8
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $5.561B $0.315B
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $227.942B 27.62
Intuitive Surgical (ISRG) United States $140.614B 84.71
Edwards Lifesciences (EW) United States $54.300B 35.34
DexCom (DXCM) United States $52.458B 79.46
IDEXX Laboratories (IDXX) United States $44.675B 52.37
Alcon (ALC) Switzerland $43.915B 31.47
IQVIA Holdings (IQV) United States $42.817B 24.84
STERIS (STE) Ireland $22.799B 26.64
Waters (WAT) United States $21.385B 31.43
SONOVA HOLDING (SONVY) Switzerland $19.521B 0.00
Hologic (HOLX) United States $17.492B 19.57
Fresenius Medical Care AG KGaA (FMS) Germany $13.139B 15.34
ShockWave Medical (SWAV) United States $12.422B 77.31
Sysmex ADR (SSMXY) Japan $10.769B 33.77
Teleflex (TFX) United States $10.295B 16.02
Globus Medical (GMED) United States $8.657B 25.38
Penumbra (PEN) United States $7.812B 88.78
Masimo (MASI) United States $6.403B 36.88
TransMedics (TMDX) United States $4.444B 421.66
Integer Holdings (ITGR) United States $3.987B 24.09
PROCEPT BioRobotics (PRCT) United States $3.504B 0.00
LivaNova (LIVN) United Kingdom $3.405B 20.22
Tandem Diabetes Care (TNDM) United States $3.031B 0.00
Elekta AB (EKTAY) Sweden $2.942B 20.18
Inari Medical (NARI) United States $2.692B 0.00
Nihon Kohden (NHNKY) Japan $2.478B 20.95
RxSight (RXST) United States $2.303B 0.00
Integra LifeSciences Holdings (IART) United States $2.166B 9.45
Veracyte (VCYT) United States $1.789B 0.00
Alphatec Holdings (ATEC) United States $1.599B 0.00
Artivion (AORT) United States $0.980B 94.00
AVANOS MEDICAL, INC (AVNS) United States $0.937B 18.23
OPKO Health (OPK) United States $0.906B 0.00
Silk Road Medical (SILK) United States $0.886B 0.00
OrthoPediatrics (KIDS) United States $0.758B 0.00
Paragon 28 (FNA) United States $0.661B 0.00
Mesa Laboratories (MLAB) United States $0.651B 22.09
SiBone (SIBN) United States $0.623B 0.00
Pacific Biosciences Of California (PACB) United States $0.596B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.567B 0.00
IRadimed (IRMD) United States $0.540B 30.25
Pulse Biosciences (PLSE) United States $0.436B 0.00
Nevro (NVRO) United States $0.410B 0.00
Treace Medical Concepts (TMCI) United States $0.349B 0.00
Tactile Systems Technology (TCMD) United States $0.325B 11.11
Sight Sciences (SGHT) United States $0.289B 0.00
AxoGen (AXGN) United States $0.261B 0.00
AngioDynamics (ANGO) United States $0.257B 0.00
EDAP TMS S.A (EDAP) France $0.256B 0.00
NeuroPace (NPCE) United States $0.246B 0.00
908 Devices (MASS) United States $0.237B 0.00
Inogen (INGN) United States $0.211B 0.00
Atossa Genetics (ATOS) United States $0.202B 0.00
Delcath Systems (DCTH) United States $0.193B 0.00
Alpha Tau Medical (DRTS) Israel $0.186B 0.00
ClearPoint Neuro (CLPT) United States $0.175B 0.00
CVRx (CVRX) United States $0.174B 0.00
Semler Scientific (SMLR) United States $0.167B 8.48
Accuray (ARAY) United States $0.166B 0.00
KORU Medical Systems (KRMD) United States $0.108B 0.00
Yubo Biotech (YBGJ) China $0.106B 0.00
Sensus Healthcare (SRTS) United States $0.105B 22.14
Spectral Diagnostics (EDTXF) Canada $0.097B 0.00
Neuronetics (STIM) United States $0.076B 0.00
Monogram Orthopaedics (MGRM) United States $0.067B 0.00
EnVVeno Medical (NVNO) United States $0.066B 0.00
Hyperfine (HYPR) United States $0.061B 0.00
Envoy Medical (COCH) United States $0.059B 0.00
InspireMD (NSPR) Israel $0.057B 0.00
SEP Acquisition (SEPA) United States $0.057B 0.00
DarioHealth (DRIO) United States $0.056B 0.00
Vicarious Surgical (RBOT) United States $0.049B 0.00
LENSAR (LNSR) United States $0.047B 0.00
Autonomix Medical (AMIX) United States $0.047B 0.00
Lucid Diagnostics (LUCD) United States $0.046B 0.00
ReWalk Robotics (LFWD) Israel $0.044B 0.00
Precision Optics (POCI) United States $0.040B 0.00
Pixie Dust Technologies (PXDT) Japan $0.036B 0.00
Rapid Micro Biosystems (RPID) United States $0.035B 0.00
Aspira Women's Health (AWH) United States $0.033B 0.00
T2 Biosystems (TTOO) United States $0.031B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.029B 0.00
Spectral AI (MDAI) United States $0.028B 0.00
Ekso Bionics Holdings (EKSO) United States $0.026B 0.00
Accelerate Diagnostics (AXDX) United States $0.020B 0.00
QT Imaging Holdings (QTI) United States $0.019B 0.00
Biosig Technologies (BSGM) United States $0.018B 0.00
PAVmed (PAVM) United States $0.018B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.017B 0.00
NexGel (NXGL) United States $0.014B 0.00
Microbot Medical (MBOT) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
Avinger (AVGR) United States $0.006B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.004B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00